OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
WUWGN58

Wuestenrot & Wuerttembergische AG

Life & Health InsuranceVerified

The company's capital structure is characterized by a debt-to-equity ratio of 1.67, indicating a moderate reliance on debt financing. Despite a negative operating income of €148 million, the firm reported a net income of €121 million, supported by a free cash flow of €92 million. However, the liquidity risk is rated as medium, and the firm has a negative net cash position after subtracting total debt. Profitability metrics show a return on equity (ROE) of 2.45% and a return on assets (ROA) of 0.17%, both below the typical thresholds for the insurance industry. These figures suggest that the company is underperforming relative to its peers in terms of capital efficiency and asset utilization. The firm's revenue is concentrated in its core life and health insurance segments, with no disclosed geographic diversification. This concentration increases exposure to regional economic downturns and regulatory shifts in the insurance sector. Looking ahead, the company is expected to maintain a stable revenue trajectory, with no significant growth or contraction projected in the next fiscal year. The capital expenditure of €43 million indicates a modest investment in infrastructure and operations. The risk assessment highlights a medium liquidity risk and a low dilution risk. The firm has not issued additional shares recently, and there is no indication of near-term dilution pressure. However, the negative net cash position and reliance on long-term debt may pose challenges in maintaining financial flexibility. Recent filings and transcripts have not revealed any major strategic shifts or operational disruptions. The company continues to operate within its traditional insurance business model, with no significant new product launches or market expansions disclosed.

30-day price · WUWGN(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyWuestenrot & Wuerttembergische AG
TickerWUWGN.DE
SectorFinancials
BusinessInsurance
Industry groupInsurance
IndustryLife & Health Insurance
AI analysis

Business. Wuestenrot & Wuerttembergische AG provides life and health insurance products, generating revenue primarily through premium income and investment returns on its insurance liabilities.

Classification. The company is classified under the Life & Health Insurance industry within the Financials sector, with a confidence level of 0.92 based on verified market data.

The company's capital structure is characterized by a debt-to-equity ratio of 1.67, indicating a moderate reliance on debt financing. Despite a negative operating income of €148 million, the firm reported a net income of €121 million, supported by a free cash flow of €92 million. However, the liquidity risk is rated as medium, and the firm has a negative net cash position after subtracting total debt. Profitability metrics show a return on equity (ROE) of 2.45% and a return on assets (ROA) of 0.17%, both below the typical thresholds for the insurance industry. These figures suggest that the company is underperforming relative to its peers in terms of capital efficiency and asset utilization. The firm's revenue is concentrated in its core life and health insurance segments, with no disclosed geographic diversification. This concentration increases exposure to regional economic downturns and regulatory shifts in the insurance sector. Looking ahead, the company is expected to maintain a stable revenue trajectory, with no significant growth or contraction projected in the next fiscal year. The capital expenditure of €43 million indicates a modest investment in infrastructure and operations. The risk assessment highlights a medium liquidity risk and a low dilution risk. The firm has not issued additional shares recently, and there is no indication of near-term dilution pressure. However, the negative net cash position and reliance on long-term debt may pose challenges in maintaining financial flexibility. Recent filings and transcripts have not revealed any major strategic shifts or operational disruptions. The company continues to operate within its traditional insurance business model, with no significant new product launches or market expansions disclosed.
Key takeaways
  • The company's debt-to-equity ratio of 1.67 suggests a moderate reliance on debt financing.
  • A return on equity of 2.45% and a return on assets of 0.17% indicate underperformance relative to industry norms.
  • Revenue is concentrated in life and health insurance segments, with no geographic diversification disclosed.
  • The firm is expected to maintain a stable revenue trajectory with no significant growth or contraction.
  • Liquidity risk is rated as medium, and the firm has a negative net cash position after subtracting total debt.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyEUR
Revenue
Gross profit
Operating income-$148.0M
Net income$121.0M
R&D
SG&A
D&A
SBC
Operating cash flow$983.0M
CapEx-$43.0M
Free cash flow$92.0M
Total assets$72.54B
Total liabilities$67.61B
Total equity$4.93B
Cash & equivalents
Long-term debt$8.24B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$4.93B
Net cash-$8.24B
Current ratio
Debt/Equity1.7
ROA0.2%
ROE2.5%
Cash conversion8.1%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Life & Health Insurance · cohort 15 companies
MetricWUWGNActivity
Op margin12.3% medp25 5.6% · p75 21.6%
Net margin2.9% medp25 0.5% · p75 10.1%
Gross margin28.2% medp25 13.4% · p75 30.5%
CapEx / revenue-2.1% medp25 -8.2% · p75 -1.2%
Debt / equity167.0%27.5% medp25 4.7% · p75 66.5%top quartile
Observations
IR observations
Mean price target18.00 EUR
Median price target19.00 EUR
High price target20.00 EUR
Low price target15.00 EUR
Mean recommendation1.67 (1=strong buy, 5=strong sell)
Strong-buy count2.00
Buy count0.00
Hold count1.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate1.69 EUR
Last actual EPS1.29 EUR
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-25 04:22 UTC#446148e9
Source: analysis-pipeline (hybrid)Generated: 2026-05-30 01:37 UTCJob: e81969c5